About this Journal Submit a Manuscript Table of Contents
International Journal of Endocrinology
Volume 2012 (2012), Article ID 359724, 5 pages
http://dx.doi.org/10.1155/2012/359724
Clinical Study

Measurement of Salivary Resistin Level in Patients with Type 2 Diabetes

1Endocrine Key Laboratory of the Ministry of Health, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing, Beijing 100730, China
2First Affiliated Hospital, Shanxi Medical University, Taiyuan 030001, China

Received 17 May 2012; Accepted 16 July 2012

Academic Editor: Panayoula C. Tsiotra

Copyright © 2012 Jinhua Yin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Steppan, S. T. Bailey, S. Bhat et al., “The hormone resistin links obesity to diabetes,” Nature, vol. 409, no. 6818, pp. 307–312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. K. H. Kim, K. Lee, Y. S. Moon, and H. S. Sul, “A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation,” Journal of Biological Chemistry, vol. 276, no. 14, pp. 11252–11256, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. C. H. Sheng, J. Di, Y. Jin et al., “Resistin is expressed in human hepatocytes and induces insulin resistance,” Endocrine, vol. 33, no. 2, pp. 135–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Bokarewa, I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski, “Resistin, an adipokine with potent proinflammatory properties,” Journal of Immunology, vol. 174, no. 9, pp. 5789–5795, 2005. View at Scopus
  5. I. A. Harsch, C. Koebnick, H. Wallaschofski et al., “Resistin levels in patients with obstructive sleep apnoea syndrome—the link to subclinical inflammation?” Medical Science Monitor, vol. 10, no. 9, pp. CR510–CR515, 2004. View at Scopus
  6. M. P. Reilly, M. Lehrke, M. L. Wolfe, A. Rohatgi, M. A. Lazar, and D. J. Rader, “Resistin is an inflammatory marker of atherosclerosis in humans,” Circulation, vol. 111, no. 7, pp. 932–939, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Axelsson, A. Bergsten, A. R. Qureshi et al., “Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance,” Kidney International, vol. 69, no. 3, pp. 596–604, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. K. Shetty, P. A. Economides, E. S. Horton, C. S. Mantzoros, and A. Veves, “Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes,” Diabetes Care, vol. 27, no. 10, pp. 2450–2457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Topkas, P. Keith, G. Dimeski, J. Cooper-White, and C. Punyadeera, “Evaluation of saliva collection devices for the analysis of proteins,” Clinica Chimica Acta, vol. 413, no. 13-14, pp. 1066–1070, 2012.
  10. D. Rachel, T. A. Alex, M. Paul, et al., “Salivery endothelin concentrations in theassessment of chronic heart failure,” The Lancet, vol. 5, pp. 468–469, 2000.
  11. P. A. Whitson and Y. M. Chen, “Saliveryendothelin and its response to postural changes inhumans,” Acta Physiologica Scandinavica, vol. 160, pp. 291–292, 1997.
  12. H. S. Randeva, E. Karteris, K. C. Lewandowski, S. Sailesh, P. O'Hare, and E. W. Hillhouse, “Circadian rhythmicity of salivary leptin in healthy subjects,” Molecular Genetics and Metabolism, vol. 78, no. 3, pp. 229–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Toda, R. Tsukinoki, and K. Morimoto, “Measurement of salivary adiponectin levels,” Acta Diabetologica, vol. 44, no. 1, pp. 20–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Mamali, N. D. Roupas, A. K. Armeni, A. Theodoropouloua, K. B. Markoua, and N. A. Georgopoulos, “Measurement of salivary resistin, visfatin and adiponectin levels,” Peptides, vol. 33, no. 1, pp. 120–124, 2011.
  15. J. R. Gavin III, K. G. M. M. Alberti, M. B. Davidson, et al., “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 20, no. 7, pp. 1183–1197, 1997. View at Scopus
  16. M. Fontana, S. Zunt, G. J. Eckert, and D. Zero, “A screening test for unstimulated salivary flow measurement,” Operative Dentistry, vol. 30, no. 1, pp. 3–8, 2005. View at Scopus
  17. M. Li, C. Y. Wu, A. L. Song, et al., “Development and preliminary application of enzyme-linked immunosorbent assay for human net insulin in serum,” Chinese Journal of Endocrinology and Metabolism, vol. 13, pp. 215–217, 1997.
  18. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Scopus
  19. M. Li, A. Fisette, X. Y. Zhao, J. Y. Deng, J. Mi, and K. Cianflone, “Serum resistincorrelates with central obesity but weakly with insulin resistance in Chinese children and adolescents,” International Journal of Obesity, vol. 33, no. 4, pp. 424–439, 2009.
  20. B. Frank, W. Sabine, P. Robert et al., “Weight loss and changes in salivary ghrelin and adiponectin: comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding,” Obesity Surgery, vol. 21, no. 5, pp. 616–624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Suleyman, H. Ihsan, H. Ibrahim et al., “A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects,” Peptides, vol. 26, no. 4, pp. 647–652, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Toda, R. Tsukinoki, and K. Morimoto, “Measurement of salivary adiponectin levels,” Acta Diabetologica, vol. 44, no. 1, pp. 20–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Mirco, W. Olaf, G. Michael, S. Renate, I. Heinrich, and Z. Johannes, “Salivary leptin as a candidate diagnostic marker in salivary gland tumors,” Clinical Chemistry, vol. 55, no. 5, pp. 914–922, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Gröschl, “The physiological role of hormones in saliva,” BioEssays, vol. 31, no. 8, pp. 843–852, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. I. E. Al-Sari, F. A. Al-Quobaili, and Y. M. Kabalan, “Serum resistin levels in Syrian obese patients with diabetes mellitus type II,” Saudi Medical Journal, vol. 28, no. 12, pp. 1890–1894, 2007. View at Scopus
  26. Y. Tokuyama, H. Osawa, T. Ishizuka et al., “Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus,” Metabolism, vol. 56, no. 5, pp. 693–698, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Fujinami, H. Obayashi, K. Ohta et al., “Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes,” Clinica Chimica Acta, vol. 339, no. 1-2, pp. 57–63, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Marchetti, R. Giannarelli, A. Masoni, P. Cecchetti, A. Di Carlo, and R. Navalesi, “Salivary immunoreactive insulin concentrations are related to plasma free-insulin levels in insulin-treated diabetic patients,” Diabete et Metabolisme, vol. 16, no. 1, pp. 16–20, 1990. View at Scopus
  29. C. Carda, N. Mosquera-LIoreda, L. Salom, et al., “Structeral and functional salivary disorders in type 2 diabetic patients,” Medicina Oral, Patologia Oral Y Cirugia Bucal, vol. 11, no. 4, pp. E309–E314, 2006.
  30. E. Boström, H. F. D'Elia, U. L. F. Dahlgren et al., “Salivary resistin reflects local inflammation in Sjögren's syndrome,” Journal of Rheumatology, vol. 35, no. 10, pp. 2005–2011, 2008. View at Scopus